Senior insider sale
President & CEO at LYRA THERAPEUTICS, INC. — senior position signals high conviction
$13.9K
1.56K shares
What this filing means
PALASIS MARIA plans to sell 1.56K shares of LYRA THERAPEUTICS, INC. valued at approximately $13.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2025ACC: 0001959173-25-004537
DirectorOfficer· President & CEO
Since Apr 2020
1.56K
Shares to sell
$13.9K
Approx. market value
1.56K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/1/2025
1.56KTotal acquired1.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Restricted Stock Vesting Compensation | 1.56K | — |
| Total | 1.56K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.56K
Market value
$13.9K
7/10/2025
Total
Units
1.56K
Value
$13.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/10/2025 | 1.56K | $13.9K | NASDAQ | Planned |
| Total | 1.56K | $13.9K | ||